Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration, Clinical Trial Study
< Back to Find a Trial

A Phase 1b, 12-Month, Randomized, Double Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Salsalate in Patients with Mild to Moderate Alzheimer’s Disease (UC-SAL-AD-001)

ID
NCT03277573
Condition Studied
Alzheimer's Disease
Phase
Phase I
Status
Closed
Intervention
Salsalate tablets
Principal Investigator
Sponsor
Adam Boxer, MD, PhD

Please go to ClinicalTrials.gov for more information.